Skip to main navigation Skip to search Skip to main content

Prospective Trial of Monocyte Count as a Biomarker of Hand-Foot Syndrome Among Patients With Soft Tissue Sarcomas Treated With Pegylated Liposomal Doxorubicin and Ifosfamide

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
JournalCureus
DOIs
StatePublished - Apr 26 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

PubMed: MeSH publication types

  • Journal Article

Cite this